Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-01-04 Sale | 2023-01-06 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 198 | $28.54 | $5,651 | 45,966 (Direct) | View |
2022-10-26 Sale | 2022-10-28 4:15 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 561 | $6.52 | $3,658 | 4,464 (Direct) | View |
2022-06-27 Sale | 2022-06-29 8:09 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 7,975 | $0.37 | $2,951 | 251,183 (Direct) | View |
2022-01-04 Sale | 2022-01-05 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 9,518 | $1.3 | $12,373 | 1,034,158 (Direct) | View |
2021-10-26 Sale | 2021-10-28 8:01 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 27,598 | $1.8 | $49,676 | 268,676 (Direct) | View |
2021-06-28 Sale | 2021-06-29 5:25 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 7,586 | $5.77 | $43,771 | 296,274 (Direct) | View |
2018-04-03 Purchase | 2018-04-05 8:07 pm | Pulmatrix Inc. | PULM | Iwicki Mark T Director | 307,000 | $0 | $0 | 921,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 1,512 | $0 | 1,512 (Direct) | View |
2023-03-06 Option Award | 2023-03-08 5:02 pm | N/A 2032-02-16 | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 49,080 | $0 | 49,080 (Direct) | View |
2023-03-06 Disposition | 2023-03-08 5:02 pm | N/A 2032-02-16 | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 49,080 | $0 | 49,080 (Direct) | View |
2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 41,700 | $0 | 45,966 (Direct) | View |
2022-10-26 Option Award | 2022-10-27 4:55 pm | N/A 2032-10-25 | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 13,667 | $0 | 13,667 (Direct) | View |
Ownership | 2022-09-14 6:08 pm | N/A N/A | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 0 | $0 | 168,343 (Direct) | View |
2022-06-21 Option Award | 2022-06-22 5:00 pm | N/A 2032-06-20 | Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director | 12,500 | $0 | 12,500 (Direct) | View |
2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-05-31 Option Award | 2022-06-02 4:05 pm | N/A 2032-05-31 | Merus N.V. | MRUS | Iwicki Mark T Director | 16,604 | $0 | 16,604 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 775,000 | $0 | 1,034,158 (Direct) | View |
2021-04-02 Option Award | 2021-07-01 6:33 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director | 158,497 | $0 | 158,497 (Direct) | View |
Ownership | 2021-06-29 7:41 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director | 0 | $0 | 116,297 (Direct) | View |
2021-06-01 Option Award | 2021-06-03 5:58 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 13,000 | $0 | 13,000 (Direct) | View |
2021-05-28 Option Award | 2021-06-02 4:10 pm | N/A 2031-05-28 | Merus N.V. | MRUS | Iwicki Mark T Director | 6,120 | $0 | 6,120 (Direct) | View |
2021-01-28 Option Award | 2021-02-01 9:45 pm | N/A 2031-01-28 | Pulmatrix Inc. | PULM | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
2021-01-04 Option Award | 2021-01-05 4:50 pm | N/A 2031-01-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer | 379,000 | $0 | 606,860 (Direct) | View |
2020-10-26 Option Award | 2020-10-28 8:24 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer | 178,300 | $0 | 227,860 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 11,432 | $14.6 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 15,398 | $17.39 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 7,500 | $1.71 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 87,368 | $28.21 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 52,421 | $31.48 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 7,840 | $34.5 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 19,755 | $19.1 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 17,500 | $16.24 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 39,567 | $34.5 | 0 (Direct) | View |
2020-06-30 Option Award | 2020-07-02 4:00 pm | N/A 2030-06-30 | Merus N.V. | MRUS | Iwicki Mark T Director | 8,631 | $0 | 8,631 (Direct) | View |
2020-06-25 Option Award | 2020-06-29 9:52 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer | 49,560 | $0 | 49,560 (Direct) | View |
2020-06-01 Option Award | 2020-06-02 6:54 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 13,000 | $0 | 13,000 (Direct) | View |
2020-05-27 Option Award | 2020-05-29 7:17 pm | N/A 2030-05-26 | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 23,238 | $0 | 62,805 (Direct) | View |
2020-04-02 Option Award | 2020-04-06 1:01 pm | N/A 2030-04-02 | Pulmatrix Inc. | PULM | Iwicki Mark T Director | 10,000 | $0 | 10,000 (Direct) | View |
2020-01-09 Option Award | 2020-01-13 5:17 pm | N/A 2030-01-09 | Pulmatrix Inc. | PULM | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
2020-01-02 Option Award | 2020-01-03 4:12 pm | N/A 2030-01-01 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer | 365,000 | $0 | 365,000 (Direct) | View |
Ownership | 2020-01-02 09:00 am | N/A 2023-06-04 | Merus N.V. | MRUS | Iwicki Mark T Director | 0 | $0 | 92,709 (Direct) | View |
Ownership | 2019-06-19 6:31 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 0 | $0 | 158,307 (Direct) | View |
2019-05-23 Option Award | 2019-05-28 9:17 pm | N/A 2029-05-23 | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 17,874 | $0 | 50,999 (Direct) | View |
2019-05-16 Option Award | 2019-05-20 4:11 pm | N/A 2029-05-16 | Pulmatrix Inc. | PULM | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
2019-01-02 Option Award | 2019-01-04 5:05 pm | N/A 2029-01-01 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer | 460,000 | $0 | 460,000 (Direct) | View |
2018-06-05 Option Award | 2018-06-06 6:02 pm | N/A 2028-06-05 | Pulmatrix Inc. | PULM | Iwicki Mark T Director | 155,000 | $0 | 155,000 (Direct) | View |
2018-05-23 Option Award | 2018-05-24 5:06 pm | N/A 2028-05-23 | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 11,250 | $0 | 40,625 (Direct) | View |